Artificial Intelligence-based Automated Echocardiographic Analysis and the Workflow of Sonographers: A randomized crossover trial - Sakamoto, Akira; Kagiyama, Nobuyuki; Sato, Eiichiro; Nakamura, Yutaka; Murata, Azusa; Kaneko, Tomohiro; Miyazaki, Sakiko; Ashikawa, Yuko; Sugihara, Kenichi; Minamino, Tohru (medRxiv, 2025)
Background This randomized crossover trial aimed to evaluate whether an artificial intelligence (AI)-based automatic analysis tool for echocardiography could improve the daily workflow of sonographers in real-world clinical practice.Methods A single-center randomized crossover trial was conducted with four certified sonographers. Each study day, the use of AI-based automatic echocardiography analysis was randomly assigned: either AI assistance (AI days) or manual workflow (non-AI days). The AI tool automatically analyzed echocardiographic images and provided measurements, enabling sonographers to focus on verifying AI-generated values. Expert echocardiologists reviewed and finalized all reports. The primary endpoint was examination efficiency, measured by examination time per patient and the number of examinations performed per day. Secondary endpoints included sonographer fatigue, the number of analyzed echocardiographic parameters, and image quality.Results A total of 585 patients were scanned over 38 study days (AI days: 317; non-AI days: 268) between Jan 30 and Mar 26, 2024. Baseline characteristics were comparable between groups. AI assistance significantly reduced examination time (13.0 ± 3.5 minutes vs. 14.3 ± 4.2 minutes, p<0.001) and increased the average number of daily examinations (16.7 ± 2.5 vs. 14.1 ± 2.5, p=0.003). Despite the higher workload, sonographers reported lower mental fatigue scores on AI days (4.1 ± 1.1 vs. 4.7 ± 0.6, p=0.039). The number of echocardiographic parameters analyzed per examination increased 3.4-fold on AI days (85 ± 12 vs. 25 ± 1, p<0.001). Differences between AI-generated measurements and final expert-endorsed values were within acceptable clinical limits for 90% of parameters. Notably, image quality significantly improved on AI days (p<0.001).Conclusions This real-world randomized trial demonstrated that AI-based echocardiographic analysis can enhance workflow efficiency, reduce sonographer fatigue, and improve image quality without compromising diagnostic integrity. Integrating AI into clinical practice holds promise for optimizing high-volume echocardiography workflows.Highlights Artificial intelligence (AI)-assisted echocardiography improved sonographer workflow efficiency.AI assistance significantly reduced examination time and increased daily scan volume. Sonographer mental fatigue was lower despite the increased workload on AI days.AI integration markedly increased the number of analyzed echocardiographic parameters.AI-enhanced workflow improved echocardiographic image quality without compromising accuracy.Graphical abstract This first-ever trial to randomize the use of an AI-based automated tool on a daily basis revealed that AI significantly enhanced the efficiency of screening echocardiography, reducing examination time despite a 3.4-fold increase in the number of parameters measured. This improved efficiency increased the number of examinations per day without increasing sonographers’ fatigue; in fact, it mitigated mental fatigue. Furthermore, being freed from the need to perform time-consuming measurements allowed sonographers to focus on image acquisition, which led to improved image quality.Competing Interest StatementDisclosures Dr. Kagiyama received research grants from AstraZeneca, EchoNous Inc. and AMI Inc. and speaker honoraria from Eli Lilly, Novartis, Otsuka pharmaceutical, and Boehringer-Ingelheim outside this work, and was affiliated with a department funded by Paramount Bed Ltd. Other authors have nothing to disclose regarding the submitted manuscript. Clinical TrialUMIN000053259 (https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060539)Clinical Protocols https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060539 Funding StatementFunding This study was partially supported by Japan Society for the Promotion of Science KAKENHI (grant number 21K18086). M3AI, the distributor of the Us2.ai platform in Japan, provided part of the software capabilities free of charge, and two personnel from M3AI participated in the study as coauthors. However, the study was audited and monitored by a researcher not involved in the study to ensure that the results were not influenced for the benefit of the company. No financial compensation was made to the company or the researchers involved. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the Research Ethics Committee of Faculty of Medicine, Juntendo University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data underlying this article cannot be shared publicly for the reason of maintaining the privacy of individuals who participated in the study. The data will be shared on reasonable request to the corresponding author.AIartificial intelligenceICCintraclass correlation coefficientsLVleft ventricular